Conquering Cancer


Eliminate preventable cancer deaths

On January 12, 2016, President Barack Obama laid out a moon shot goal in his final State of the Union address: to end cancer as we know it. Cancer, however, isn’t one disease; it’s many. While medicine and science continue making steady progress, cancer remains the number one killer, behind heart disease. The Cancer Visioneers team will take a fresh look at the disease, dissecting it from every angle to come up with innovative approaches to preventing, detecting and treating this devastating disease.

I'm in!

Help us detect cancer early and everywhere and save lives!

Join others in supporting the Conquering Cancer XPRIZE.  Please push the “I’m in!” button to demonstrate your support for detecting cancer early and everywhere.  We only ask for your email so we can keep you informed when we are ready to launch! Thank you for your support!

“We are at a pivotal moment in the battle against cancer, bolstered by a new federal initiative – the Cancer Moonshot.”



Currently, 36 percent of all cancer across the globe is preventable. Fifty percent of cancer deaths in the U.S. alone are preventable. Cancer prevention and diagnosis is ripe for innovation. Imagine how many lives could have been saved if everyone had access to a simple cancer screening test.

The Cancer Moonshot provides an opportunity to modify our approach to preventing, detecting, treating and curing cancer. It is also a chance to maximize scientific, analytical, and multidisciplinary collaborative advancements to double our rate of progress over the next five years.

In response to the Cancer Moonshot call to action, the Cancer Visioneers Team is designing a challenge where bridges are built, opportunity reaches the motivated, and ingenuity is rewarded. The XPRIZE model will activate the crowd and unite collaboration and ingenuity across this wide cancer ecosystem.

More on Conquering Cancer

Prize Sponsor

As a leader in innovative solutions, Deloitte brings unparalleled depth of health care knowledge and experience; unique access to a global ecosystem of diverse points of views; and lasting commitment to helping colleagues, communities, friends and family who have been touched by cancer.

By sponsoring the Conquering Cancer XPRIZE, Deloitte brings a powerful platform of knowledge, access and commitment to accelerate cancer research in areas that could include accurate, early detection and therapy treatments, leveraging exponential technologies and inter-disciplinary collaboration.

Mariya Filipova

Mariya Filipova
Prize Developer

For the last seven years, Mariya has focused on the impact of exponential technologies in the life sciences and healthcare industry and worked with providers, health plans, policy makers, and investors to capitalize on these opportunities. As a Senior Manager in Deloitte Consulting Innovations’ Healthcare Team, she focuses on how disruptive technologies, processes and business models shape product development, care delivery, research, and education. She taps into past experience as an entrepreneur, VC and general manager to help connect unconventional partners to collaborate and solve healthcare’s biggest challenges transforming our current system from “sick-care” into an ecosystem of health.

MBA, Innovation & Entrepreneurship, Harvard Business School
BA, Economics and International Relations, Mount Holyoke College
BA, Economics, Rheinische Friedrich-Wilhelms-Universität Bonn

Andrew Ryscavage

Andrew Ryscavage
Prize Developer

Andrew is a Manager at Deloitte and advises on science, health, and innovation strategy. Prior to Deloitte, Andrew spent 14 years at the National Cancer Institute as a Cancer Biologist and Manager. His research focused on understanding the genetic determinants of tumors of high progression risk and elucidating the involvement of the microenvironment in cancer progression. Andrew also worked in science diplomacy, working with partner countries and agencies to foster scientific innovation and partnerships. He completed his Embassy Science Fellowship out of the US Embassy in Lisbon, Portugal, where he studied the economic impact of the bioeconomy.

MBA, Georgetown University, McDonough School of Business
Master’s, International Relations, American University
Bachelor’s, Molecular, Cellular & Developmental Biology, University of Colorado, Boulder

Winona Dorris

Heather Eaton
Deloitte Fellow

Shawna Butler
Sponsor Resource

Asif Dhar
Sponsor Resource

Beth Meagher
Sponsor Resource

Timothy Small
Sponsor Resource

Audrey Vaughn
Sponsor Resource